| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 37, Issue 2 160-179, Copyright © 1975 by American Psychosomatic Society
ORIGINAL ARTICLES |
JW Jefferson
The tricyclic antidepressants have potent and complex effects on the cardiovascular system, both directly and through interactions with other drugs. Through a combination of anticholinergic activity, direct myocardial depressant activity and an effect on the adrenergic neuron, they can cause a combination of arrhythmias, blood pressure abnormalities and congestive heart failure. These changes, although most common with overdose, can occur at therapeutic levels. In addition a number of drug-drug interactions can occur between the tricyclics and agents used in the treatment of cardiovascular disease, as exemplified by tricyclic antagonism of the antihypertensive effect of guanethidine. Awareness of these factors is necessary to insure proper therapeutic utilization of the tricyclics as well as to treat effectively their toxicity.
This article has been cited by other articles:
 |
|
 |
|
  H. Cohen, R. S. Hoffman, and M. A. Howland Antidepressant Poisoning and Treatment: A Review and Case Illustration Journal of Pharmacy Practice, August 1, 1997; 10(4): 249 - 270. [Abstract] [PDF]
|
|
|
|
 |
|
 H. M. Babigian and L. B. Guttmacher Epidemiologic Considerations in Electroconvulsive Therapy Arch Gen Psychiatry, March 1, 1984; 41(3): 246 - 253. [Abstract] [PDF]
|
|
|
|
 |
|
 W. G. Bissell and R. L. Bank Tricyclic Overdose JAMA, May 1, 1981; 245(17): 1731 - 1732. [Abstract] [PDF]
|
|
|
|
 |
|
 R. W. Clark, H. S. Schmidt, and D. E. Schuller Sleep-Induced Ventilatory Dysfunction in Down's Syndrome Arch Intern Med, January 1, 1980; 140(1): 45 - 50. [Abstract] [PDF]
|
|
|
|
|
|
G. M. Brown, H. C. Stancer, H. Moldofsky, J. Harman, J. T. Murphy, and R. N. Gupta Withdrawal From Long-term High-Dose Desipramine Therapy: Clinical and Biological Changes Arch Gen Psychiatry, October 1, 1978; 35(10): 1261 - 1264. [Abstract] [PDF]
|
|
|
|
 |
|
 L. E. HOLLISTER Drug Spotlight Program: Treatment of Depression with Drugs Ann Intern Med, July 1, 1978; 89(1): 78 - 84. [Abstract] [PDF]
|
|
|
|
|
|
R. M. WILDER Psychologic and Psychosocial Aspects of Medical Practice: An Annotated Bibliography Ann Intern Med, March 1, 1978; 88(3): 435 - 440. [Abstract] [PDF]
|
|
|
|
|
|
D. Burckhardt, E. Raeder, V. Muller, P. Imhof, and H. Neubauer Cardiovascular Effects of Tricyclic and Tetracyclic Antidepressants JAMA, January 16, 1978; 239(3): 213 - 216. [Abstract] [PDF]
|
|
|
|
|
|
R. F. Klein Behavioral and Psychological Processes in Ischemic Heart Disease Arch Intern Med, December 1, 1977; 137(12): 1672 - 1673. [Abstract] [PDF]
|
|
|
|
|
|
D. S. Robinson and E. Barker Tricyclic Antidepressant Cardiotoxicity JAMA, November 1, 1976; 236(18): 2089 - 2090. [Abstract] [PDF]
|
|
|
|
|
|
D. Avery and G. Winokur Mortality in Depressed Patients Treated With Electroconvulsive Therapy and Antidepressants Arch Gen Psychiatry, September 1, 1976; 33(9): 1029 - 1037. [Abstract] [PDF]
|
|
|
|
|
|
J. Tobis and B. N. Das Cardiac Complications in Amitriptyline Poisoning: Successful Treatment With Physostigmine JAMA, April 5, 1976; 235(14): 1474 - 1476. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
